Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival
Scott D. Brown, Robin M. Warren, Ewan A. Gibb, et al.
Genome Research (2014) Vol. 24, Iss. 5, pp. 743-750
Open Access | Times Cited: 577

Showing 1-25 of 577 citing articles:

The Immune Landscape of Cancer
Vésteinn Thórsson, David L. Gibbs, Scott D. Brown, et al.
Immunity (2018) Vol. 48, Iss. 4, pp. 812-830.e14
Open Access | Times Cited: 4567
Neoantigens in cancer immunotherapy
Ton N. Schumacher, Robert D. Schreiber
Science (2015) Vol. 348, Iss. 6230, pp. 69-74
Open Access | Times Cited: 4320
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong, Francesca Finotello, Mihaela Angelova, et al.
Cell Reports (2017) Vol. 18, Iss. 1, pp. 248-262
Open Access | Times Cited: 3706
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney, Sachet A. Shukla, Catherine J. Wu, et al.
Cell (2015) Vol. 160, Iss. 1-2, pp. 48-61
Open Access | Times Cited: 3317
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M. Van Allen, Diana Miao, Bastian Schilling, et al.
Science (2015) Vol. 350, Iss. 6257, pp. 207-211
Open Access | Times Cited: 2591
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini, Justin M. Balko, Ingrid A. Mayer, et al.
Nature Reviews Clinical Oncology (2016) Vol. 13, Iss. 11, pp. 674-690
Open Access | Times Cited: 2383
Adoptive cell transfer as personalized immunotherapy for human cancer
Steven A. Rosenberg, Nicholas P. Restifo
Science (2015) Vol. 348, Iss. 6230, pp. 62-68
Open Access | Times Cited: 2200
Classifying Cancers Based on T-cell Infiltration and PD-L1
Michele W.L. Teng, Shin Foong Ngiow, Antoni Ribas, et al.
Cancer Research (2015) Vol. 75, Iss. 11, pp. 2139-2145
Open Access | Times Cited: 1310
Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy
Teresa Davoli, Hajime Uno, Eric C. Wooten, et al.
Science (2017) Vol. 355, Iss. 6322
Open Access | Times Cited: 1213
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
Nicholas McGranahan, Rachel Rosenthal, Crispin T. Hiley, et al.
Cell (2017) Vol. 171, Iss. 6, pp. 1259-1271.e11
Open Access | Times Cited: 1129
Translational biology of osteosarcoma
Maya Kansara, Michele W.L. Teng, Mark J. Smyth, et al.
Nature reviews. Cancer (2014) Vol. 14, Iss. 11, pp. 722-735
Closed Access | Times Cited: 1104
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
Mahesh Yadav, Suchit Jhunjhunwala, Qui Phung, et al.
Nature (2014) Vol. 515, Iss. 7528, pp. 572-576
Closed Access | Times Cited: 1093
Biological and Therapeutic Impact of Intratumor Heterogeneity in Cancer Evolution
Nicholas McGranahan, Charles Swanton
Cancer Cell (2015) Vol. 27, Iss. 1, pp. 15-26
Open Access | Times Cited: 1007
Towards personalized, tumour-specific, therapeutic vaccines for cancer
Zhuting Hu, Patrick A. Ott, Catherine J. Wu
Nature reviews. Immunology (2017) Vol. 18, Iss. 3, pp. 168-182
Open Access | Times Cited: 897
Combination cancer immunotherapies tailored to the tumour microenvironment
Mark J. Smyth, Shin Foong Ngiow, Antoni Ribas, et al.
Nature Reviews Clinical Oncology (2015) Vol. 13, Iss. 3, pp. 143-158
Closed Access | Times Cited: 845
Coinhibitory Pathways in Immunotherapy for Cancer
Susanne H.C. Baumeister, Gordon J. Freeman, Glenn Dranoff, et al.
Annual Review of Immunology (2016) Vol. 34, Iss. 1, pp. 539-573
Closed Access | Times Cited: 835
Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma
Marios Giannakis, Xinmeng Jasmine Mu, Sachet A. Shukla, et al.
Cell Reports (2016) Vol. 15, Iss. 4, pp. 857-865
Open Access | Times Cited: 827
Dendritic cell-based immunotherapy
Rachel Lubong Sabado, Sreekumar Balan, Nina Bhardwaj
Cell Research (2016) Vol. 27, Iss. 1, pp. 74-95
Open Access | Times Cited: 759
Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
Eryn Blass, Patrick A. Ott
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 4, pp. 215-229
Open Access | Times Cited: 743
Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes
Sachet A. Shukla, Michael S. Rooney, Mohini Rajasagi, et al.
Nature Biotechnology (2015) Vol. 33, Iss. 11, pp. 1152-1158
Open Access | Times Cited: 637
Association of Polymerase e–Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1
Brooke E. Howitt, Sachet A. Shukla, Lynette M. Sholl, et al.
JAMA Oncology (2015) Vol. 1, Iss. 9, pp. 1319-1319
Open Access | Times Cited: 609
Turning the corner on therapeutic cancer vaccines
Robert E. Hollingsworth, Kathrin U. Jansen
npj Vaccines (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 609
Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer
Kyle C. Strickland, Brooke E. Howitt, Sachet A. Shukla, et al.
Oncotarget (2016) Vol. 7, Iss. 12, pp. 13587-13598
Open Access | Times Cited: 561
Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy
Mihaela Angelova, Pornpimol Charoentong, Hubert Hackl, et al.
Genome Biology (2015) Vol. 16, Iss. 1
Open Access | Times Cited: 485
Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies
Roberta Zappasodi, Taha Merghoub, Jedd D. Wolchok
Cancer Cell (2018) Vol. 33, Iss. 4, pp. 581-598
Open Access | Times Cited: 468
Page 1 - Next Page

Scroll to top